- Home
- TLSA vs FEAM Comparison
TLSA vs FEAM Comparison
Compare TLSA & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- FEAM
- Stock Information
- Founded
- TLSA 2013
- FEAM 2016
- Country
- TLSA United Kingdom
- FEAM United States
- Employees
- TLSA N/A
- FEAM N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- FEAM Major Chemicals
- Sector
- TLSA Health Care
- FEAM Industrials
- Exchange
- TLSA Nasdaq
- FEAM Nasdaq
- Market Cap
- TLSA 175.3M
- FEAM 71.5M
- IPO Year
- TLSA 2000
- FEAM N/A
- Fundamental
- Price
- TLSA $1.59
- FEAM $3.60
- Analyst Decision
- TLSA
- FEAM Strong Buy
- Analyst Count
- TLSA 0
- FEAM 2
- Target Price
- TLSA N/A
- FEAM $121.00
- AVG Volume (30 Days)
- TLSA 261.4K
- FEAM 12.7K
- Earning Date
- TLSA 07-11-2025
- FEAM 05-15-2025
- Dividend Yield
- TLSA N/A
- FEAM N/A
- EPS Growth
- TLSA N/A
- FEAM N/A
- EPS
- TLSA N/A
- FEAM N/A
- Revenue
- TLSA N/A
- FEAM N/A
- Revenue This Year
- TLSA N/A
- FEAM N/A
- Revenue Next Year
- TLSA N/A
- FEAM N/A
- P/E Ratio
- TLSA N/A
- FEAM N/A
- Revenue Growth
- TLSA N/A
- FEAM N/A
- 52 Week Low
- TLSA $0.63
- FEAM $2.82
- 52 Week High
- TLSA $1.91
- FEAM $31.51
- Technical
- Relative Strength Index (RSI)
- TLSA 53.42
- FEAM 33.46
- Support Level
- TLSA $1.54
- FEAM $3.41
- Resistance Level
- TLSA $1.81
- FEAM $3.85
- Average True Range (ATR)
- TLSA 0.12
- FEAM 0.28
- MACD
- TLSA 0.01
- FEAM -0.06
- Stochastic Oscillator
- TLSA 50.00
- FEAM 15.24
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About FEAM 5E Advanced Materials Inc.
5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.